Cytopathology in Focus: Paris System: a new paradigm for urinary cytology

Create PDF

1. Rosenthal DL, Wojcik EM, Kurtycz DFI, eds. The Paris System for Reporting Urinary Cytology. New York: Springer; 2016.
2. Netto GJ. Molecular genetics and genomics progress in urothelial bladder cancer. Semin Diagn Pathol. 2013;30(4):313–320.
3. Cheng L, Zhang S, MacLennan GT, Williamson SR, Lopez-Beltran A, Montironi R. Bladder cancer: translating molecular genetic insights into clinical practice. Hum Pathol. 2011;42(4):455–481.
4. Knowles MA. Molecular pathogenesis of bladder cancer. Int J Clin Oncol. 2008;13(4):287–297.
5. van Rhijn BW. Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancer. Urol Oncol. 2012;30(4):518–523.
6. Prather J, Arville B, Chatt G, et al. Evidence-based adequacy criteria for urinary bladder barbotage cytology. Journal of the American Society of Cytopathology. 2015;4(2):57–62.
7. VandenBussche CJ, Rosenthal DL, Olson MT. Adequacy in voided urine cytology specimens: the role of volume and a repeat void upon predictive values for high-grade urothelial carcinoma. Cancer Cytopathol. 2016;124(3):174–180.
8. Barkan GA. Enough is enough: adequacy of voided urine cytology. Cancer Cytopathol. 2016;124(3):163–166.
9. Wojcik EM. What should not be reported as atypia in urine cytology. Journal of the American Society of Cytopathology. 2015;4(1):30–36.
10. Barkan GA, Tabatabai L, Sturgis C, Kurtycz DFI, Souers RJ, Nayar R. In preparation for the Paris System for Reporting Urinary Tract Cytopathology (TPSRUTC): observations from the 2014 supplemental questionnaire of the College of American Pathologists (CAP) Cytopathology Interlaboratory Comparison Program (CICP) [abstract]. Mod Pathol. 2015;28(suppl 2):83A.

Dr. Barkan is an associate professor of pathology and urology, vice chair of education, and director of cytopathology, Loyola University Medical Center, Maywood, Ill. Dr. Wojcik, president of the American Society of Cytopathology, is chair of pathology and the Helen M. and Raymond M. Galvin professor of pathology and urology, Loyola University Medical Center. Dr. Rosenthal is a professor emerita of pathology, Division of Cytopathology, Johns Hopkins School of Medicine. Dr. Kurtycz is a professor of pathology and laboratory medicine, University of Wisconsin-Madison, and medical director, Wisconsin State Laboratory of Hygiene. Dr. Kurtycz is a member of the CAP Cytopathology Committee.